search Created with Sketch.

Search Results

Show Filters plus Created with Sketch.

Refine By Content Type plus Created with Sketch.

Refine By Year plus Created with Sketch.

Sort By:

Relevance Date

Evolving Strategies in Early- Stage Glaucoma Management

A focus on the complementary roles of selective laser trabeculoplasty and sustained-release drug delivery.

Inder Paul Singh, MD; Lorraine M. Provencher, MD; Emily M. Schehlein, MD; Manjool Shah, MD; Swarup Swaminathan, MD; and Zarmeena Vendal, MD

Feature

The Worried Well

The overdiagnosis and overtreatment of glaucoma are growing concerns.

James D. Brandt, MD

Landmark Studies

Glaucoma Therapy Delivers Great Patient and Financial Value

The cost-utility analysis associated with glaucoma therapy.

Gary C. Brown, MD, MBA; Joshua D. Stein, MD, MSc, MS; Melissa M. Brown, MD, MN, MBA; Richard P. Wilson, MD; and George L. Spaeth, MD

Landmark Studies

Glaucoma Therapy Delivers Great Patient and Financial Value

The cost-utility analysis associated with glaucoma therapy.

Gary C. Brown, MD, MBA; Joshua D. Stein, MD, MSc, MS; Melissa M. Brown, MD, MN, MBA; Richard P. Wilson, MD; and George L. Spaeth, MD

Landmark Studies

Glaucoma Therapy Delivers Great Patient and Financial Value

The cost-utility analysis associated with glaucoma therapy.

Gary C. Brown, MD, MBA; Joshua D. Stein, MD, MSc, MS; Melissa M. Brown, MD, MN, MBA; Richard P. Wilson, MD; and George L. Spaeth, MD

Landmark Studies

Costs and Financial Gain Associated With Glaucoma Therapy

Ophthalmic interventions deliver significant patient and financial value.

Gary C. Brown, MD, MBA; Melissa M. Brown, MD, MN, MBA; Joshua D. Stein, MD, MSc, MS; Richard P. Wilson, MD; and George L. Spaeth, MD

Landmark Studies

Costs and Financial Gain Associated With Glaucoma Therapy

Ophthalmic interventions deliver significant patient and financial value.

Gary C. Brown, MD, MBA; Melissa M. Brown, MD, MN, MBA; Joshua D. Stein, MD, MSc, MS; Richard P. Wilson, MD; and George L. Spaeth, MD

Landmark Studies

Costs and Financial Gain Associated With Glaucoma Therapy

Ophthalmic interventions deliver significant patient and financial value.

Gary C. Brown, MD, MBA; Melissa M. Brown, MD, MN, MBA; Joshua D. Stein, MD, MSc, MS; Richard P. Wilson, MD; and George L. Spaeth, MD

Landmark Studies

Measuring the Impact of Glaucoma and the Value of Treatment

A primer on value-based medicine.

Gary C. Brown, MD, MBA; Melissa M. Brown, MD, MN, MBA; Joshua D. Stein, MD, MSc, MS; Richard P. Wilson, MD; and George L. Spaeth, MD

Landmark Studies

Measuring the Impact of Glaucoma and the Value of Treatment

A primer on value-based medicine.

Gary C. Brown, MD, MBA; Melissa M. Brown, MD, MN, MBA; Joshua D. Stein, MD, MSc, MS; Richard P. Wilson, MD; and George L. Spaeth, MD

Landmark Studies

Measuring the Impact of Glaucoma and the Value of Treatment

A primer on value-based medicine.

Gary C. Brown, MD, MBA; Melissa M. Brown, MD, MN, MBA; Joshua D. Stein, MD, MSc, MS; Richard P. Wilson, MD; and George L. Spaeth, MD

Industry News and Innovations

Clinician Scientist's Corner

CLINICIAN SCIENTIST'S CORNER

Joshua D. Stein, MD, MS

VIEW MORE